Pharmacogenetics of Target Genes Across the Warfarin Pharmacological Pathway

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.45, Iss.12, 2006-01, pp. : 1189-1200

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenetics of Target Genes Across Doxorubicin Disposition Pathway: A Review

Current Drug Metabolism, Vol. 11, Iss. 1, 2010-01 ,pp. : 115-128

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics of genes across the doxorubicin pathway

By Jamieson David Boddy Alan V

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 10, 2011-10 ,pp. : 1201-1210

Informa Healthcare

Access to resources Recommend Favorite

The Adiponectin Signaling Pathway as a Novel Pharmacological Target

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 12, 2006-12 ,pp. : 1331-1340

Bentham Science Publishers

Access to resources Recommend Favorite

Shifting paradigms in the pharmacogenetics of warfarin

By Gak Eva Halkin Hillel

Pharmacogenomics, Vol. 9, Iss. 10, 2008-10 ,pp. : 1373-1375

Future Medicine

Access to resources Recommend Favorite

Warfarin Pharmacogenetics: Economic Considerations

By Hughes Dyfrig A.

PharmacoEconomics, Vol. 25, Iss. 11, 2007-01 ,pp. : 899-902

Adis International

Access to resources Recommend Favorite